Tower Research Capital LLC (Trc) Regulus Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,186 shares of RGLS stock, worth $15,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,186
Previous 6,914
61.79%
Holding current value
$15,101
Previous $10,000
70.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RGLS
# of Institutions
70Shares Held
53.5MCall Options Held
13.7KPut Options Held
7K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$17.4 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$8.73 Million0.73% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$6.75 Million1.54% of portfolio
-
Octagon Capital Advisors LP New York, NY4.85MShares$6.55 Million1.71% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$5.36 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $19.8M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...